GPs are free to prescribe semaglutide to all eligible patients in line with NICE guidelines after long-term shortages have ...

GLP-1 drugs like Ozempic can help kidney transplant patients avoid organ failure and live longer, a new study sugges ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows.

These GLP-1 agonists include semaglutide, liraglutide, and dulaglutide, now marketed as Ozempic, Wegovy, Saxenda, Victoza, ...

Adults with T2D taking semaglutide, other glucagon-like peptide 1 receptor agonists (GLP-1 RAs; dulaglutide and exenatide), or non-GLP-1 RA medications (empagliflozin, sitagliptin, and glipizide ...

Adults with T2D taking semaglutide, other glucagon-like peptide 1 receptor agonists (GLP-1 RAs; dulaglutide and exenatide), or non-GLP-1 RA medications (empagliflozin, sitagliptin, and glipizide) from ...

Share on Pinterest GLP-1 drugs may protect the brain from inflammation, some studies say, but others warn they may increase depression risk. Image credit: James Manning – PA Images/Getty Images ...

Yao Qin, PhD, assistant professor at the University of California, Santa Barbara, is no stranger to the work involved in staying healthy with type 1 diabetes (T1D). Diagnosed in 2011, she deals ...

Trulicity (dulaglutide) is not a weight loss drug, but people receiving it may lose weight. Higher doses of Trulicity typically result in more weight loss. The FDA has not approved Trulicity as a ...

“This is what the people voted for” — or so we hear from the White House with each slashed program. But is it? Did people really vote to tear apart the National Institutes of Health (NIH) and lay ...

BURLINGAME, CA, UNITED STATES, January 28, 2025 /EINPresswire.com/ -- Global GLP-1 receptor agonist market is estimated to be valued at USD 28.14 billion in 2025 and ...